×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
DMRA – damora therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
DMRA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/25
06:24 am
dmra
Damora Therapeutics, Inc. Common Stock (DMRA) was upgraded by Royal Bank Of Canada to "moderate buy".
Medium
Report
Damora Therapeutics, Inc. Common Stock (DMRA) was upgraded by Royal Bank Of Canada to "moderate buy".
4/24
09:00 am
dmra
Damora Therapeutics, Inc. Common Stock (DMRA) is now covered by Royal Bank Of Canada. They set an "outperform" rating and a $40.00 price target on the stock.
Low
Report
Damora Therapeutics, Inc. Common Stock (DMRA) is now covered by Royal Bank Of Canada. They set an "outperform" rating and a $40.00 price target on the stock.
3/30
08:00 am
dmra
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/25
10:00 am
dmra
Damora Therapeutics, Inc. Common Stock (DMRA) is now covered by Evercore Inc. They set an "outperform" rating and a $46.00 price target on the stock.
Medium
Report
Damora Therapeutics, Inc. Common Stock (DMRA) is now covered by Evercore Inc. They set an "outperform" rating and a $46.00 price target on the stock.
3/23
08:00 am
dmra
Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors
High
Report
Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors
3/19
04:10 pm
dmra
Damora Therapeutics Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
Medium
Report
Damora Therapeutics Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: